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Phylogenetically conserved toll-like receptors (TLR) recognize ‘‘pathogen-associated molecular patterns’’. Upon
binding of ligands, TLR initiate innate immune response in immune and most likely epithelial cells. The TLR4
isoform is considered as a lipopolysaccharide (LPS) receptor. As shown here, a rat-tongue-derived epithelial cell
line RTE2 expressed TLR4 mRNA and functional protein. LPS-treated RTE2 cells responded with the transient
expression of inducible nitric oxide synthase (iNOS), an effector protein of TLR4 involved in the innate immune
defense of monocytes. iNOS induction occurred along a nuclear factor-jB (NF-jb)-dependent pathway and cor-
related with the increased production of NO. Moreover, LPS and lipid A were potent inhibitors of proliferation of
RTE2 cells, of mouse keratinocytes, and mouse epidermis in vivo. The inhibition depended on lipid A structure, i.e.,
it was related to the endotoxin activity of LPS and at least in vitro was in part mediated by NF-jB. C57Bl/10 ScCr
mice, lacking a functional TLR4, did not respond with growth inhibition, strongly suggesting a TLR4-mediated
effect. RTE2 proliferation was also inhibited by transforming growth factor b (TGFb) and tumor necrosis factor a
(TNFa), whereas interferon c (IFNc) was a weak inhibitor. But the growth-inhibitory effect of LPS on RTE2 cells was
not mediated by TNFa, TGFb, or NO. It is concluded that besides induction of innate immune responses, LPS
specifically induces growth arrest in epithelial tongue cells and keratinocytes in vitro and in mouse epidermis in a
TLR4-dependent but cytokine- and NO-independent manner.
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Lipopolysaccharides (LPS), the main components of the
outer cell wall of Gram-negative bacteria, are ranked among
the most biologically active compounds (Raetz and Whit-
field, 2002). Upon contact with eukaryotic organisms they
evoke dramatic systemic effects that, if worst comes to
worst, culminate in endotoxic shock syndrome (Lei et al,
2003), mainly as a consequence of complement activation
and the activation of the innate immune system.
The recognition of pathogen-associated molecular pat-
terns (PAMP) such as LPS, lipoteichoic acid of Gram-pos-
itive bacteria, or other structural moieties of the outer
surface of microorganisms is of major importance for the
initiation of the innate immune defense (Janeway and Med-
zhitov, 2002). Antigen-presenting cells such as macrophag-
es and dendritic cells express PAMP-specific receptors that
belong to the Toll-like receptor (TLR) family consisting of at
least ten members in mammals (Rock et al, 1998). TLR are
mammalian homologues of TOLL-receptors, originally
cloned from and characterized in Drosophila. They were
shown to regulate dorso-ventral patterning in the larvae
(Stein et al, 1991) and additionally to initiate anti-microbial
defense (Lemaitre et al, 1996). All TLR are type I trans-
membrane receptors consisting of an intracellular domain
exhibiting structural homologies to the IL-1 receptor re-
quired for downstream signaling and a leucine-rich extra-
cellular domain, involved in recognition of PAMP (Akira
and Takeda, 2004). LPS is specifically recognized by TLR4
(Poltorak et al, 1998; Qureshi et al, 1999, Lien et al, 2000).
There is evidence for the existence of endogenous TLR4
ligands including heat shock protein 70 and fibrinogen (Beg,
2002). Cellular responses triggered by their binding to and
activation of TLR4 seem to be related to inflammation and
need to be further characterized.
In the LPS-TLR4-induced signaling cascade, which leads
to innate immune responses, the transcriptional activation
of nuclear factor-kB (NF-kB)-responsive genes is consider-
ed to be a crucial step (Akira and Takeda, 2004).
Abbreviations: EDTA, ethylene diamin-tetraacetate; EGTA, ethyl-
eneglycol-bis(b-aminoethylether)-tetraacetate; FACS, fluores-
cence-activated cell sorting; FCS, fetal calf serum; ID, inhibitory
dose; IFNg, interferon g; IL-1b, interleukin-1b; L-NAME, N-nitro-L-
arginine methylester; L-NMMA, NG-monomethyl-L-arginine; LPS,
lipopolysaccharide; MEM, minimal essential medium; NF-kb, nu-
clear factor-kB; NNA, N-nitro-L-arginine; NOS, nitric oxide synt-
hase; PBS, phosphate-buffered saline; Tris, trishydroxymethyl-
aminomethane; TGFb, transforming growth factor b; TLR, toll-like
receptor; TNFa, tumor necrosis factor a
Copyright r 2005 by The Society for Investigative Dermatology, Inc.
553
LPS effects on macrophages have been found to be
mediated by pro-inflammatory cytokines such as IL-1b and
tumor necrosis factor a (TNFa), as well as inducible nitric
oxide synthase (iNOS), which generates NO from L-arginine
(Jaffrey and Snyder, 1995; Werling et al, 2004).
Only recently, it was recognized that both antigen-pre-
senting cells and epithelial cells possess the capacity to
contribute to innate immunity via an activation of the TLR-
family. In intestinal cells (Cario et al, 2000) and in human
keratinocytes, the expression of TLR4 and TLR2 (Kawai
et al, 2002; Song et al, 2002; Pivarcsi et al, 2003) that leads
to the production of IL-1 and IL-8 has been reported (Song
et al, 2002; Mempel et al, 2003).
Here we report that endotoxic LPS induces iNOS ex-
pression and activity in a NF-kB-dependent pathway in a
rat-tongue-derived epithelial cell line, RTE2, which is shown
to express TLR4 mRNA and protein similar to the tissue of
origin. Furthermore, it is shown that LPS species are highly
potent non-toxic inhibitors of cell proliferation, both in RTE2
cells and keratinocyte cultures as well as mouse epidermis
in vivo. At least in cell culture the anti-proliferative effect of
LPS seemed to be mediated directly via the NF-kB path-
way, but not indirectly via endogenous production of
cytokines such as transforming growth factor b (TGFb),
TNFa, and interferon g (IFNg) or via NO. These data may
point to TLR4-mediated regulation of epithelial cell home-
ostasis.
Results
Rat epithelial cells express TLR4 By RT-PCR and/or
Northern blot analysis, TLR4 mRNA was detected in the rat-
tongue-derived epithelial cell line RTE2 (Fig 1A, B) and in
various rat tissues including tongue (Fig 1B). In addition,
TLR4 protein could be demonstrated in RTE2 cell extracts
by means of immunoblotting with a TLR4-specific antibody
(Fig 1C) and by immune fluorescence staining of RTE2 cells
(Fig S1).
LPS induces iNOS expression and stimulates the pro-
duction of NO To investigate the function of TLR4 in RTE2
cells, the effect of the TLR4 agonist LPS (Escherichia coli
0111:B4) on the expression of iNOS, a well-known effector
protein of LPS in macrophages (Aktan, 2004), was analyzed.
Two types of NOS were distinguished (Hobbs et al, 1999),
namely, a constitutive NOS (cNOS), which is ubiquitously
expressed in at least two isoforms (neuronal ncNOS and
endothelial ecNOS), and an inducible NOS (iNOS). Immuno-
blotting using NOS isozyme-specific antibodies revealed
that untreated cells expressed iNOS protein in very small
amounts that became visible only upon prolonged exposure
of the immunoblots (Fig 2A, C). No immune signals for ec-
NOS and ncNOS could be detected (Fig 2A). When treated
with LPS the cells responded with a strong expression of
iNOS. This effect was maximal after 4–8 h and depended on
the dose with an EC50 of approximately 100 ng LPS per mL
(Fig 2B, C). The induction by LPS of iNOS protein correlated
with a significant increase in NOS activity as measured in
cell-free preparations. In contrast to cNOS, iNOS activity
does not depend on Ca2þ /calmodulin. In LPS-stimulated
cells, an increased Ca2þ -independent NOS activity was
measured, which was only weakly stimulated by raising the
Ca2þ concentration up to 0.6 mM (Fig 2D). In LPS-treated
cells, NOS activity measured as citrulline generation or
nitrite/nitrate production was suppressed by the NOS in-
hibitors N-nitro-L-arginine (NNA) and N-nitro-L-arginine me-
thylester (L-NAME) (Marletta, 1994), respectively (Fig 2D, E).
LPS-stimulated iNOS expression is NF-jB-depend-
ent TLR4 has been shown to signal via NF-kB in le-
ukocytes, resulting in the nuclear translocation of the
transcription factor (Martin and Wesche, 2002). As expect-
ed, LPS induced the nuclear translocation of NF-kB in RTE2
cells, as shown by immunofluorescence analysis (Fig 3A–
C). To examine the role of NF-kB in mediating the LPS-
induced iNOS expression, the effect of an NF-kB inhibitory
peptide (NF-kB-IP) was checked. This cell-permeable pep-
tide inhibits nuclear translocation of the NF-kB active com-
plex (Lin et al, 1995). Therefore, RTE2 cells were pre-treated
with NF-kB-IP or vehicle solution for 18 h and subsequently
challenged with LPS in the presence or absence of NF-kB-
IP for further 6 h. Immunoblot analysis of iNOS protein
Figure 1
Toll-like receptor (TLR)4 expression in the
tongue-derived epithelial cell line RTE2. (A)
Representative RT-PCR analysis of TLR4 mRNA
(upper panel) from subconfluent RTE2 cells
(N¼5). As an internal control, b-actin was am-
plified (lower panel). A negative control, PCR
without cDNA gave no signals. M, puc-DNA size
marker. (B) Northern blot analysis of TLR4 mRNA
levels in subconfluent RTE2 cells (lane 1), colon
(lane 2), tongue (lane 3), and heart (lane 4) of rat.
The TLR4-specific hybridization signal was ap-
parent at 3.4 kb. For control of loaded RNA, et-
hidium bromide-stained 28S and 18S rRNA are
shown (lower panel). (C) Representative
immunoblot of TLR4 protein expression in un-
treated (lane 1) and lipopolysaccharide (LPS)-
treated (lane 2) subconfluent RTE2 cells (N¼4,
each) using anti-TLR4 antibody. LPS treatment (1000 ng per mL for 72 h) did not change the steady-state level of TLR4 expression in RTE2 cells
(upper panel). Immunoblot detection of b-actin served as a control (middle panel). The assessment of the specificity of the immunoreaction was
performed by incubating with the primary antibody adsorbed with the respective peptide antigen at a 500-fold molar excess (lower panel). Arrows
indicate specific TLR4 immunosignals. Protein sizes are given in kilodalton (kDa).
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revealed that LPS-stimulated iNOS expression was mark-
edly inhibited by NF-kB-IP, whereas the treatment of control
cells with NF-kB-IP alone did not show an effect (Fig 3D).
LPS inhibits proliferation in RTE2 cells Upon a single
treatment of RTE2 with LPS, growth inhibition became ap-
parent, as evident from an increased number of G0/G1 and
a decreased number of S phase cells (Fig 4A). The repeated
treatment of these cells with endotoxically highly active LPS
species from 13 different sources resulted in a pronounced
Figure 2
Effect of lipopolysaccharide (LPS) on nitric oxide synthase (NOS)
expression in RTE2 cells. (A) Immunoblots obtained with extracts
from cells treated with LPS (500 ng per mL) or vehicle (Co) for 6 h using
anti-NOS-isozyme-specific antibodies. Cell lysates from macrophages
(iNOS), endothelium cells (ecNOS), and brain (ncNOS) served as pos-
itive controls (PC), indicated by an asterisk. (B) Immunoblots of cells
treated with increasing concentrations of LPS for 6 h or (C) with 500 ng
per mL LPS for the times indicated. The molecular weight standards are
given in kDa. Results in A–C are representative data out of two to six
independent experiments. (D) Ca2þ -independent NOS-activity. RTE2
cells were grown with or without LPS (500 ng per mL) for 6 h. NOS
activity (production of [3H]-citrulline from [3H]-arginine) was determined
in cell-free preparations with and without Ca2þ . The final concentration
of the NOS inhibitor NNA was 1 mM. Values represent means of N¼ 3
independent extracts  SEM. (E) Cells were grown with or without LPS
(500 ng per mL) and NOS inhibitor L-NAME (N-nitro-L-arginine methyl-
ester) (4 mM) for 30 h. NO products in culture supernatants were
measured by means of the nitrate/nitrite-detection kit. N¼3  SEM;
Co, vehicle-treated control cultures.
Figure3
Nuclear factor-jB (NF-jB)-dependent inducible nitric oxide synt-
hase (iNOS) expression in lipopolysaccharide (LPS)-stimulated
RTE2 cultures. (A) Indirect immunofluorescence analysis of the local-
ization of NF-kB in (A) vehicle and (B) LPS-treated (1000 ng per mL for
45 min) RTE2 cells using anti-NF-kB p65 antibodies (diluted 1:25) as
primary and Cy3-coupled anti-goat IgG as secondary antibody (diluted
1:2000). (C) Negative control, omission of the primary antibody. Mag-
nifications:  40. (1 cm¼ 14.5mm) Representative pictures of four cul-
tures each from two independent experiments. (D) Immunoblot
detection of iNOS in RTE2 cells pre-treated with NF-kB-inhibitory pep-
tide (IP) (8 mM) or vehicle solution (Co) for 18 h and subsequently chal-
lenged with 500 ng per mL LPS in the presence or absence of NF-kB-IP
(IP) for further 6 h. b-actin served as a control for protein loadings.
Protein size markers are given in kDa. One of two experiments showing
similar results. Treatment with 8 mM NF-kB-IP alone led to a 14% re-
duction of RTE2 cell numbers only after 72 h.
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but transient inhibition of proliferation, the course and de-
gree of which were independent of the LPS type (Fig 4B). At
days 4–6, the reduction in cell number caused by 500 ng per
mL LPS was comparable to the inhibitory effect of 5 ng per
mL TGFb used as a positive control. Afterwards, however,
the cells became refractory to repeated endotoxin treat-
ment, reaching the cell number of the control cultures at day
11, i.e., at the time of maximal confluency. Such an effect
was not observed upon TGFb treatment. The inhibitory
effects of lipid A, and TGFb were entirely reversible upon
removal of the inhibitors (Fig S2).
At doses X50 ng per mL LPS inhibition approached a
maximum between 50% and 80%, depending on the initial
plating density of RTE2 cells and the culture time. In con-
trast, 5 ng per mL of TGFb caused an inhibition of up to
90% during the test period (Fig 4C). The inhibitory effect
was also monitored by means of pulse-labeling of RTE2 cell
DNA with [3H]thymidine (Fig 4D). As a half-maximal inhib-
itory concentration, 10 ng per mL, approximately 100 pM,
was estimated for LPS as compared with 1 ng per mL, i.e.,
80 pM, for TGFb.
DNA labeling was also suppressed by LPS (E. coli 0111)
or lipid A in primary mouse keratinocytes, in the mouse
keratinocyte line HEL 30, and in Swiss-3T3 fibroblasts, with
IC50 values of approximately 100 pM. Primary human ker-
atinocytes did not respond to LPS up to a concentration of
10 nM.
The anti-proliferative effect of LPS depends on lipid A
structure Both bacterial and synthetic lipid A (C506) inhib-
ited RTE2 cell proliferation (Fig 4C) and DNA labeling (Fig
4D) almost as effectively as LPS. This inhibitory effect crit-
ically depended on the lipid A structure. Thus, the biosyn-
thetic lipid A precursor Ia (C406), which is unable to induce
several endotoxin effects (Loppnow et al, 1989; Beutler and
Rietschel, 2003), did not inhibit RTE2 proliferation (Fig 4C).
Moreover, LPS and lipid A from Rhodopseudomonas spe-
cies, which showed a greatly reduced endotoxic efficacy
due to an altered lipid A moiety (Mayer et al, 1989; Beutler
and Rietschel, 2003), exhibited only a weak inhibitory effect
(Fig 4D). A suppression by Rhodopseudomonas LPS/lipid A
or C406 of the anti-proliferative effect of highly endotoxic
LPS as found for other LPS effects (Raetz et al, 1991) was
not observed.
The anti-proliferative effect of LPS is mediated in part by
NF-jB Whether the growth-inhibitory effect of LPS de-
pended on NF-kB, similar to the induction of iNOS, was
addressed. In fact, non-toxic concentrations of NF-kB-IP
significantly restored cell growth in RTE2 cells, which were
exposed to LPS for 72 h, suggesting that the growth-inhib-
itory effect of LPS was mediated at least in part by NF-kB
(Fig 5).
Figure 4
Inhibition of RTE2 cell proliferation by lipopolysahharide (LPS) and
lipid A. (A) FACS analysis of the cell cycle distribution of RTE2 cells
treated at 96 h after seeding with 500 ng per mL LPS (black bars) or
vehicle (white bars) for 24 h. Bars represent means  SD of 5–7 indi-
vidual cultures from four experiments. Student’s t test: po0.005 (),
po0.0005 (). (B) Effect of LPS, lipid A, and transforming growth
factor b (TGFb) on the proliferation of RTE2 cells. The cell numbers are
given for untreated control (&), and TGFb-treated cultures (  , 5 ng per
mL, NX3, SDp  10%). The mean of the results obtained with 13
different LPS species (  ), i.e., from Eshericha coli strains 026:B6,
055:B5, 0111:B4, 0127:B8, 0128:B12, K235, from Salmonella abortus
equi and enteritidis, from Serratia marcescens, Klebsiella pneumoniae,
Shigella flexneri, Enterobacte-spec and Pseudones aeruginosa (500 ng
per mL each). The effects of the individual LPS species were identical
within a range of  15%. The cells were seeded at zero time and the
substances were added at day 1 and afterwards with each medium
change (at days 4, 6, and 8). (C) Dose–response curves for the effects
of TGFb (  ), LPS from E. coli 0111 (  ), synthetic lipid A C506 (m), and
lipid A precursor la C406 (4). RTE2 cell numbers were determined at
day 8 after plating. This experiment differed from that shown in (B) in
that the plating density of the cells was 3  103 instead of 2  104 cells
per well. NX3, SDp  10%. (D) Dose–response curves of the inhib-
itory effects of LPS from E. coli 0111 (  ), LPS from Salmonelia abortus
equi (  ), LPS from Rhodopseudomonas capsulatus (&), lipid A from
Salmonelia minnesota (m), and pentaacyl-diphosphoryl-lipid A from
Rhodopseudomonas sphaeroides (’), and TGFb (  ) on DNA labeling
in RTE2 cells. These were treated at zero time and pulse-labeled with
[3H]thymidine (5 mCi per mL for 30 min) after 15 h. The specific DNA
labeling of the untreated controls was 1–2  104 cpm per well
(¼100%). NX5, SDp10%.
Figure5
Mediation of the anti-proliferative effect of lipopolysaccharide
(LPS) by Nuclear factor-jB (NF-jB). Twenty four hours after seeding,
RTE2 cells were treated with LPS and NF-kB-inhibitory peptide (IP) as
indicated for 72 h. Cell numbers were determined by the MTT test.
Values represent means of N¼4  SD of one out of two independent
experiments. Student’s t test: p-value o0.05 (), po0.005 ().
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The anti-proliferative effect of LPS is not mediated by
growth-inhibitory cytokines or NO LPS is known to in-
duce cytokines, some of which have been shown to inhibit
the growth of keratinocytes in vitro (Shipley et al, 1986;
Nickoloff et al, 1988; Pillai et al, 1989; Symington, 1989). In
addition, high concentrations of NO have been shown to
impair growth of macrophages (Zhuang and Wogan, 1997).
Hence, dose–response curves were determined for the
three most relevant growth-inhibitory cytokines (TGFb,
TNFa, and IFN-g) in RTE2 cells, resulting in calculated IC50
values of approximately 1 ng per mL (80 pM) for TGFb, and
10 ng per mL (approx. 600 pM) for TNFa, and 410 mg per
mL for IFN-g. The IC50 for IFN-g, however, was un-physi-
ologically high (Fig 6A). Using neutralizing antibodies di-
rected against TNFa and TGFb we were able to rule out their
possible mediator function in LPS-induced growth inhibi-
tion, since these antibodies were unable to overcome the
inhibitory effect of LPS (Fig 6B, C). The treatment of control
cultures with neutralizing anti-TNFa antibodies resulted in
an increased DNA labeling suggesting a constitutive release
of TNFa. but the TNFa levels in the supernatants of un-
treated and LPS-treated RTE2 cells were below the de-
tection level of a bioassay. IL-1b, another mediator of
endotoxin effects, was not included in these experiments,
since this cytokine was found to stimulate rather than inhibit
keratinocyte proliferation (Maas-Szabowski et al, 1999).
Furthermore, the NOS inhibitors L-NAME and NG-mono-
methyl-L-arginine (L-NMMA) (Marletta, 1994, see also Fig
2E), when tested at concentrations of 0.5–4 mM and 0.1–1
mM, respectively, did not significantly change the cell
number in control cultures and were unable to attenuate
the anti-proliferative effect of LPS (500 ng per mL) when
incubated with RTE2 cells for 120 h (Fig 6D, Fig S3), show-
ing that NO did not influence growth in RTE2 cells.
TLR4-dependent inhibition of epidermal proliferation in
mouse skin by LPS Recently, LPS-induced TLR4 signaling
has been reported for keratinocytes (Song et al, 2002).
Thus, the mouse epidermis was chosen to study the effect
of LPS in vivo. TLR4 mRNA was expressed in this tissue as
demonstrated by RT-PCR analysis, and LPS injection was
followed by a transient expression of iNOS protein within 3 h
(Fig 7).
As shown in the table, an intraperitoneal (i.p.) injection of
LPS (E. coli ) or lipid A (Salmonella) resulted in a concentra-
tion-dependent inhibition of DNA labeling in the epidermis of
the NMRI mouse strain. This inhibition was observed already
at doses of 30–300 mg per kg body weight, whereas symp-
toms of illness became apparent only at doses 41 mg per
kg and lethal effects at even higher doses (X4 mg per kg).
No symptoms of inflammation were observed upon local
application of LPS (E. coli 0111; 1 mg) and lipid A (salmonella
0.1 mg) onto the mouse ear (not shown). A similar effect of
LPS on inhibition of DNA labeling in epidermis was meas-
ured in the LPS-responder mice of the C57Bl/ScSn strain
(Table I). Treatment of TLR4-defective, LPS-resistant C57Bl/
10 ScCr mice (Qureshi et al, 1999) with LPS even at a dose
of up to 1.5 mg per kg, i.p. did not cause a significant sup-
pression of DNA labeling in epidermis in vivo.
Discussion
In this study, we present data showing that epithelial RTE2
cells from tongue express TLR4 mRNA and functional pro-
tein. Stimulating the cells with LPS, a well-documented
bacterial ligand of this receptor, resulted in the time- and
concentration-dependent induction of iNOS protein. As
expected from experiments with LPS-induced iNOS in
Figure 6
The anti-proliferative effect of lipopolysaccha-
ride (LPS) is not mediated by growth-inhibitory
cytokines or nitric oxide (NO). (A) Dose–
response curves of the effects of transforming
growth factor b (TGFb) (  ), tumor necrosis factor
a (TNFa) (m), interferon g ( ), and LPS (  , Es-
cherichia coli 0111) on RTE2 cell proliferation.
The experiment was carried out as described for
Fig 4C. NX4, SDo  10%. (B) Effect of a neu-
tralizing anti-TNFa antibody on the inhibition by
LPS of DNA labeling in RTE2 cells. These were
treated with LPS and anti-TNFa antibody as in-
dicated, whereby the antibody was added 30 min
prior to LPS application. 15 h later DNA labeling
was performed as described for Fig 4. N¼4  SD.
(C) Effect of anti-TGFb antibody on the anti-pro-
liferative action of TGFb and LPS on RTE2 cells.
The cells were treated with TGFb or LPS (Salmo-
nella abortus equi) at concentrations as indicated,
either in the absence (gray bars) or in the pres-
ence (white bars) of blocking anti-TGFb antibody
(15 mg per mL). The antibody was added to the
cultures 30 min prior to TGFb or LPS application.
DNA labeling was performed as described. Each
bar represents the mean of three assays
(SEMo  10%). The experiment was repeated
once, yielding similar results. (D) Cells were grown
without (white bars) or with LPS (500 ng per mL,
hatched bars) and NOS inhibitors L-NAME as in-
dicated for 120 h. Cell numbers were determined
by the MTT test. N¼3  SEM. Data from one of
two experiments showing similar results.
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macrophages (Aktan, 2004), this induction occurred in an
NF-kB-dependent manner, because iNOS-expression was
strongly inhibited by an inhibitor peptide of NF-kB. ecNOS
or ncNOS protein were detected neither in control, nor in
LPS-stimulated RTE2 cells. In addition, the increased iNOS
expression levels correlated with an increased Ca2þ -inde-
pendent NOS activity. Thus, the elevated NO concentra-
tions in LPS-treated cultures were due to iNOS activity.
Macrophage-derived NO has been shown to inhibit DNA
synthesis in microorganisms due to inactivation of FeS-
containing ribonucleotide reductase (Hobbs et al, 1999).
Our data suggest that epithelial tongue cells may contribute
to microbial defense, similar to immune and epithelial cells
of the epidermis (Pivarcsi et al, 2003). Recently, human
keratinocytes in vitro have been shown to possess an NF-
kB-dependent killing activity against the human pathogen
Candida albicans, which was discussed to be mediated by
TLR2 and TLR4 (Pivarcsi et al, 2003).
It remains to be clarified whether NO concentrations in
LPS-treated RTE2 cells are sufficiently high to kill Gram-
negative bacteria upon direct contact in vitro and particu-
larly in vivo.
In keratinocytes, the activation of NF-kB has been linked
to a cell cycle arrest and a hypoproliferative state of epi-
dermis in vivo (Kaufmann and Fuchs, 2000) rather than to a
stimulation of proliferation as was described for immune
cells (Gerondakis et al, 1998). Accordingly, LPS indeed im-
paired cell cycling and growth in RTE2 cells, as shown here.
This occurred at least in part along an NF-kB-dependent
pathway, since inhibition of NF-kB activation by the NF-kB-
IP (Lin et al, 1995) restored cell growth in LPS-treated cells.
Currently, other TLR4-coupled signaling pathways cannot
be ruled out as being involved in the observed anti-prolif-
erative effect of LPS. Besides the activation of the IKK (in-
hibitor of nuclear factor-kB-kinase) complex leading to NF-
kB activation, there is evidence that LPS may stimulate
other kinase pathways (Akira and Takeda, 2004; Huang
et al, 2004).
LPS turned out to be a potent inhibitor of RTE2 cell pro-
liferation in vitro, exhibiting IC50 values of approximately 10
ng per mL (100 pM), i.e., approximating the efficacy of TGFb
(1 ng per mL corresponding to 80 pM), the most potent
inhibitor of keratinocyte proliferation in cell culture. This is a
first report on an anti-proliferative effect of LPS. The inhi-
bition of cell proliferation was reversible and not accompa-
nied by apoptosis, the rate of which was determined as the
sub-2n-DNA content by FACS analysis (data not shown).
The anti-proliferative effect of LPS on RTE2 cells was spe-
cifically determined by the lipid A moiety, i.e., correlated
with the endotoxin activity of LPS and was not mediated by
IFNg, TNFa, and TGFb, i.e., cytokines known to inhibit ker-
atinocyte proliferation (Shipley et al, 1986; Nickoloff et al,
1988; Pillai et al, 1989; Symington, 1989).
This observation appears to be contrary to a previous
paper showing an augmentation by LPS of the anti-prolif-
erative effect of IFNg on human keratinocytes in vitro (Heck
et al, 1992); however, 100–1000-fold higher LPS doses were
used in this study. Inhibitor experiments indicated that, un-
der these conditions, the suppression of cellular prolifera-
tion was mediated by NO produced upon LPS/IFNg-
dependent induction of an apparently Ca2þ -dependent
Table I. Effect of an i.p. injection of LPS (Escherichia coli 0111)
and lipid A (S.minnesota) on DNA labeling in mouse epidermis
in vivo
Treatment
Dose
(lg per kg)
DNA labellinga (mean cpm
per lg in % of control  SD)
LPS-sensitive
LPS-resistant
C57Bl/10 ScCrNMRI
C57Bl/
10ScSn
Solvent
control
0 100  26 100  15 100  19
LPS 30 60  5 n.d. n.d.
300 45  16 45  23 105  22
900 33  8 n.d. n.d.
1500 n.d. n.d. 84  12
Lipid A 30 63  11 n.d. n.d.
300 42  18 n.d. n.d.
aDNA labelling was performed as described for Fig 4. 100%¼ 58  15
cpm per mg DNA (NMRI),¼ 124  15 (C57Bl/10 ScSn), and¼ 119  22
cpm per mg DNA (C57Bl/10 ScCr). Each value represents the mean of six
animals  SD. 4–15 mg DNA per assay.
LPS, lipopolysaccharides; i.p., intraperitoneal; n.d., not done.
Figure 7
Toll-like receptor (TLR)4 mRNA and inducible nitric oxide synthase
(iNOS) expression in mouse epidermis. (A) RT-PCR analysis of TLR4
mRNA in epidermis (409 bp product) as compared with tongue and
spleen (upper panel). As an internal control, b-actin (430 bp product)
was amplified (lower panel). The tongue and spleen served as a positive
controls; NC, negative control: PCR without cDNA. M, puc-DNA size
marker. (B) Effect of an i.p. injection of LPS (Escherichia coli, 600 mg per
kg) on the expression of iNOS protein in the epidermis of NMRI mice.
Lipopolysaccharide was given at zero time and the animals were killed
at the times indicated. iNOS protein was determined in epidermal ex-
tracts by immunoblotting. Vehicle-treated animals served as controls
(Co). PC, macrophage extract as positive control for iNOS. Data from
one of two experiments showing similar results.
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NOS activity (Heck et al, 1992). In RTE2 cells, however, NO
was not involved in the anti-proliferative effect of LPS, since
iNOS induction required an LPS dose that was about ten
times higher than that for the inhibition of cell proliferation,
and the anti-proliferative effect of LPS treatment was not
impaired by NOS inhibition. In addition, a specific guanylate
cyclase inhibitor, Ly 85353, proved to be without any effect
when tested in concentrations up to 10 mM (data not
shown), which completely inhibit cGMP production in other
systems (O’Donnell and Owen, 1986), thus ruling out the
possibility of the LPS effect occurring along the NO-cGMP
pathway of signal transduction (Jaffrey and Snyder, 1995).
The anti-proliferative effect of LPS was not restricted to
the in vitro situation but was also found in the epidermis of
different mouse strains in vivo. Measuring the DNA-labeling
index in this tissue revealed a high biological activity (ID50
p15 mg per kg upon i.p. injection in vivo as compared to 1
and 50 ng per mL in cell culture). Strong evidence for a
TLR4-mediated effect came from our experiments using
LPS-resistant mice that exhibited a deletion of the TLR4
gene (Polotrak et al, 1998; Qureshi et al, 1999). These an-
imals failed to respond to LPS injection by a decrease of
epidermal DNA synthesis.
The evolutionary conservation of TLR4 from Drosophila
to vertebrates may indicate, similar to Toll in the dors-
oventralization of the Drosophila embryo, an additional role
in vertebrates, i.e. the regulation of morphogenetic pattern-
ing or other processes different from innate immunity. In this
context it may be of interest that the LPS effect on prolif-
eration of RTE2 cells and keratinocytes in vitro and in vivo
strongly resembled the anti-proliferative effects of skin ex-
tracts thought to be caused by an elusive chalone (Gamer
et al 2003), i.e. a tissue-specific inhibitor of epidermal DNA
synthesis.
Our observation of growth inhibition in epithelial cells by
LPS deserves further investigations to clarify whether the
LPS-induced effect is relevant in LPS-induced innate im-
munity in the epidermis or whether LPS mimics an endog-
enous not yet characterized TLR4 ligand involved in the
regulation of epidermal homeostasis.
Material and Methods
Materials LPS from Rhodopseudomonas capsulatus was a gen-
erous gift from H. Mayer (Max-Planck-Institut (MPI), Freiburg, Ger-
many), pentaacyl-diphosphoryl lipid A from Rhodopseudo monas
sphaeroides was from Advanced Medical Research (Madison,
Wisconsin), synthetic lipid A C506 from ICN Biochemicals (Cleve-
land, Ohio), and lipid A precursor I a (C406) from Sebak (Aiden-
bach, Germany). Other LPS and lipid A species, TNFa, and IFNg
were from Sigma, (Taufkirchen, Germany). Human TGFb, L-NAME,
L-NMMA, and NF-kB inhibitor peptide were from Calbiochem-Me-
rck Biosciences (Darmstadt, Germany). An anti-pan-specific TGFb
antibody (AB-100-NA) also neutralizing rat TGFb (Zhou et al, 2004)
was from RnD Systems (Wiesbaden, Germany) and a neutralizing
anti-mouse/rat TNFa antibody from Pharmingen, BD (Heidelberg,
Germany). Polyclonal anti-mouse TLR4 antibody (SC-12511, re-
acts with TLR4 of mouse and rat origin) and anti-NF-kB antibody
(SC-109) were from Santa Cruz (Heidelberg, Germany). Monoclon-
al antibodies directed against macrophage iNOS, ecNOS, and
ncNOS and reactive against rat and mouse NOS were from Trans-
duction Laboratories (Lexington, Kentucky). Anti-mouse and goat
IgG-horseradish peroxidase conjugates and Cy3-conjugated anti-
goat IgG were from Dianova (Hamburg, Germany). Nitrate/nitrite
colorimetric assay kit was from Alexis (Gru¨nberg, Germany), and
the NOSdectect assay kit from Stratagene (Amsterdam, the Neth-
erlands). L-[2,3,4,5-3H]-arginine (specific activity 1.5–2.6 Tbq per
mmol) and [3H]thymidine (specific activity 925 G Bq per mmol)
were from Amersham-Buchler (Braunschweig, Germany). Tissue
culture medium and supplements were from Biochrom (Berlin,
Germany), and Serva (Heidelberg, Germany). Costar plates were
from Falcon (Oxnard, California).
Cell culture RTE2 cells were grown as described (Richter et al,
1984). For the establishment of growth curves, 2  104 cells per
well were plated in 24-well plates and grown in 0.5 mL medium
(4  MEM, 5% FCS) at 341C and 5% CO2. The medium was
changed at days 1, 4, 6, and 8. Together with each medium change
the cells were supplied with the test substances, if not stated oth-
erwise. The cells were counted using a Coulter Counter (Coulter
Electronics, Krefeld, Germany). For DNA labeling, 2000 cells per
well were plated in 96-well plates and grown as described (Richter
et al, 1984). One day prior to confluency, the cultures were treated
with the test compounds for 15 h, and afterwards incubated with
[3H]thymidine (5 mCi per mL) for 30 min and processed as de-
scribed (Richter et al, 1984). The MTT test was carried out as
described (Mu¨ller-Decker et al, 1994). For analysis of TLR4 and
NOS, 5  105 cells were seeded into 100 mm dishes. Four days
later, the test substances, dissolved as described below, were
added. Primary mouse keratinocytes were prepared from newborn
NMRI mice as described (Fu¨rstenberger et al, 1986). The trans-
formed mouse keratinocyte line Hel 30 was kindly supplied by N. E.
Fusenig, DKFZ (Heidelberg, Germany). Primary human keratin-
ocytes were from Clonetics (San Diego, California).
Animal experiments Seven-week-old LPS-resistant female C57
Bl/10 ScCr and age-matched LPS-sensitive female C57 Bl/10
ScSn mice (Coutinho and Meo, 1977; Qureshi et al, 1999) pur-
chased from H. Mossmann (MPI, Freiburg, Germany), and female
NMRI mice from Deutsche Versuchstieranstalt (Hannover, Germany)
were kept as described (Furstenberger et al, 1986). LPS (1 mg per
mL) was dissolved in aqueous 0.025%–0.05% triethylamine and,
after appropriate dilution with phosphate-buffered saline (PBS), 0.2
mL was i.p. injected per animal. The injections were administered
at 6 p.m. At 9 a.m. next day, the animals received an i.p. injection of
0.33 mCi [3H]thymidine in 0.2 mL PBS and were killed 1 h later. The
skin was dissected, epidermal DNA was prepared, and its spe-
cific radioactivity was measured as described (Richter et al, 1984).
Animal studies were approved by regulatory authorities (Re-
gierungspra¨sidium Karlsruhe, Germany, No. 109/95).
TNFa assay TNFa was determined by means of a bioassay as
published (Flick and Gifford, 1984). L929 cells were kindly supplied
by D. L. Ma¨nnel (DKFZ, Heidelberg, Germany). Within a detection
limit of 0.02 pg per mL, no TNFa could be monitored in the supe-
rnatant of RTE2 cultures treated with LPS or lipid A in concentra-
tions of up to 2 mg per mL for up to 24 h, the assay being carried
out every hour. In contrast, primary peritoneal mouse macrophag-
es responded to LPS (10 ng per mL, E. coli 0111) with a 4-fold
increase of TNFa within 4 h.
Immunoblot analysis For NOS analysis, RTE2 cells were ho-
mogenized in 2 mL IP buffer (10 mM Tris HCl, pH 7.4, 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 0.2 mM Na3VO4, 0.2 mM phe-
nylmethylsulfonylfluoride (PMSF), 1% Triton X-100, 0.5% NP40, 10 mg
per mL each of leupeptin and aprotinin). Accordingly, epidermis
was pooled from two mice in 2 mL IP buffer and homogenized
using a polytron PT 3000 (Kinematica, Littau-Luzern, Switzerland).
150 mg of the supernatant protein obtained after centrifugation
(1300 g, 41C, 10 min, Eppendorf microcentrifuge) (Eppendorf,
Hamburg, Germany) was used for the immunoblot analysis as de-
scribed (Mu¨ller-Decker et al, 2003). For TLR4 analysis, cells were
extracted by means of 2 mL 2  LS buffer per 100 mm dish (0.5 M
Tris per HCl, 5% b-mercaptoethanol, 10% glycerol, 3% SDS,
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0.01% bromphenol blue, 1 mM PMSF, pH 6.8). 2% of each heat-
denatured extract was subjected to immunoblot analysis. Proteins
separated in 7.5% SDS polyacrylamide gels and electroblotted
onto PVDF-membranes were handled according to the protocol
recommended by the supplier of the anti-iNOS antibody. Antigen
was detected by means of the ECL detection system (Amersham
Biosciences, Freiburg, Germany) exposing Fujii Super RX films for
various times (Fuji Photo Film Co, Tokyo, Japan). The signals have
been recorded within the linear range of the film.
Determination of NOS activity NOS activity was measured with
an NOS detect assay kit. To this end, cells washed in PBS 1 mM
EDTA and scraped into 1 mL PBS 1 mM EDTA were collected by
centrifugation (Biofuge, (13,730 g), 2 min, 41C) (Biofuge, Hercules,
California). The pellets were resuspended in homogenization buffer
(25 mM Tris HCl, pH 7.4, 10 mM EDTA, 10 mM EGTA) and sonified
with a Branson sonifier Branson Ultrasonic Corp., Danbury,
Connecticut (three times five impulses, 50% output control). De-
struction of cells was checked by a trypan blue exclusion test. The
homogenate was centrifuged (Biofuge, 13,730 g, 41C, 5 min) and
10 mL of the supernatant (8–10 mg per mL protein) was used for
NOS activity assays. The assay was carried out in a total volume of
50 mL containing 25 mM Tris HCl, pH 7.4, 3 mM BH4, 1 mM FAD,
1 mM FAM, 1 mM NADPH, and 1 mCi [3H]-arginine. As a positive
control, the activity of neuronal NOS from cerebellum extract
(Stratagene, Heidelberg, Germany) was determined in the pres-
ence of 0.6 mM CaCl2. Cell extract boiled for 20 min served as a
negative control. The specificity of the NOS assay was controlled
by adding the NOS inhibitor NNA (final concentration 1 mM) to the
samples. After incubation at 371C for 30 min, the reaction was
stopped by adding 400 mL 50 mM HEPES 5 mM EDTA (pH 5.5) and
vigorous shaking. One hundred microliters of equilibrated resin
was added, the mix was shaken for 5 min, transferred into spin
cups, and after centrifugation (Biofuge, 13,730 g, 30 s) the radio-
activity of the supernatant was determined by liquid scintillation
counting. The purity of the [3H]-citrulline fraction was checked by
thin-layer chromatography using 1:10 of each sample and CH3OH
per NH4OH (6:1, vol/vol) as a solvent with citrulline and arginine as
reference compounds. Radioactivity was analyzed by a radioden-
sitometer (Berthold, Bad Wildbad, Germany) and reference com-
pounds were made visible by iodination. Total NOS activity was
calculated by subtracting control values (obtained with boiled cell
extract) from measured values.
Nitrate/nitrite determination To measure the total nitrate/nitrite
concentration in culture supernatants, a colorimetric assay kit was
used. The nitrate–reductase reaction was carried out for 3 h at
room temperature and the nitrate standard curve established for
the range of 1.25–35 mM. Values obtained for culture medium alone
were subtracted from values obtained for cell culture supernatants.
FACS For FACS analysis, 5  105 cells were seeded into 100 mm
dishes. Four days later, the test substances, dissolved as de-
scribed, were added for the time indicated. RTE2 cells were tryp-
sinized, washed twice in PBS, fixed in ethanol, and stained with
5 mM 4,6-diamidino-2-phenylindole. Stained cells were analyzed
for their DNA content by a FACSCan cytometer equipped with the
lysis II Cell Fit software (Pharmingen, BD).
Protein determination Protein was determined by means of the
BioRad DC Protein Assay (Biorad, Mu¨nchen, Germany) using bo-
vine serum albumin as a standard.
RNA isolation, RT-PCR- and northern blot analysis Total RNA
was isolated from tissue biopsies or cell cultures as described
(Mu¨ller-Decker et al, 2003). Using 1 mg of total RNA, first-strand
cDNA synthesis was performed with a cDNA cycle kit (Invitrogen,
Leek, The Netherlands) and oligp dT primers according to the
manufacturer’s protocol. PCR was carried out using the primer
pairs 50-CCA CCA TTT ACA GTT CGT CA-30 and 50-CTC CAC AGC
CAC CAG ATT-30 for rat TLR4 (462 bp amplicon) and 50-GGT ATA
TCA GAA ATG CTA CA-30 and 50-GTC CTT GAG AAG GTT GAG
AAG TCC-30 for mouse TLR4 (409 bp fragment). To ensure the
fidelity of mRNA extraction and reverse transcription, samples
were subjected to PCR amplification of b-actin. Primer pairs were
50-AAACTGGAACGGTGAAGGC-30 and 50-GCTGCCTCAACACCT-
CAAC-30 for mouse b-actin (430 bp amplicon), and 50-AAA CTG
GAA CGG TGA AGG C-30 and 50-AAA CGG TCT CAT CCA CGT
TC-30 for rat b-actin (490 bp amplicon). Genomic amplification
products were ruled out using intron-spanning primers. Amplicon
DNA sequences were verified by cloning purified DNA (Qiaquick
gel extraction kit, Qiagen, Hider, Germany) into PCR II TOPO vector
(Invitrogen), sequencing by means of the ABI Big Dye Terminator
Cycle Sequencing Ready Reaction kit and an ABI Prism 310 Ge-
netic analyzer (Perkin-Elmer/Applied Biosystems, Weiterstadt,
Germany), and using the Heidelberg Unix Sequence Analysis Re-
sources (HUSAR) software. For Northern blot analysis 10–20 mg of
total RNA were separated in 1.4% agarose gels and transferred to
membranes as described (Mu¨ller-Decker et al, 2003). Hybridization
was performed with a-32P-dCTP-labeled rat TLR4-cDNA (specific
activity: 1.25  109 cpm per mg DNA). Autoradiograms were de-
veloped after 12 days of exposure of KODAK-X-Omat films using
intensifying screens at 751C.
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